Virios Therapeutics, Inc. (VIRI) Q3 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the Verios Therapeutics, Inc. Third Quarter 2023 Earnings Update. At this time, all participants have been placed on a listen-only mode. Please be advised that today's call is being recorded at the company's request. At this time, I'd like to turn the call over to Angela Walsh, Senior Vice President of Finance and Treasurer for Verios Therapeutics. Please proceed, Angela. Thank you. Good morning, everyone, and thank you for joining us on today's conference call. We are pleased to be with you today to discuss various therapeutics third quarter financial results and to give you a corporate update. Please note that our financial results press release is now available on our website. Before we begin, I'd like to remind everyone that statements made during this conference call will include four looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. which involve risks and uncertainties that can cause actual results to differ materially from the information expressed or implied by these four LICN statements. For more information regarding such risks and uncertainties, please see the risk factors outlined in the company's filings with the SEC. Any four LICN statements are made only as of today and we disclaim any obligation to update these four LICN statements other than as required by law. please see the four-legged statement section in our financial results press release issued this morning for more information. Now, it is my pleasure to turn the call over to our CEO, Greg Duncan. Greg? Thank you very much, Angela, and good morning, everybody, and thank you for joining today's quarter three 2023 earnings update. We'll be going through several slides over the course of the next 15 or 20 minutes, and then we'll...